investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Pharmacogenetics of Phase II Drug Metabolizing Enzymes

Richard M Weinshilboum

2 Collaborator(s)

Funding source

National Institute of General Medical Sciences (NIH)

Liewei Wang

Mayo Clinic (Rochester)

Rochester, United States

Related projects

James K Turkson

Salicylic Acid-Based Small-Molecule Stat3 Inhibitors for Anticancer Therapy

Breast

Filippo G Giancotti

Mechanisms governing metastatic reactivation of breast cancer.

Breast

Fariba Behbod

Elucidating Cellular Heterogeneity Among Cancer Stem Cells by Raman Spectroscopy

Breast

Radiation Oncology

Laura Alice Stransky

Elucidating the mechanism of mTORC1 activation by amino acids

Breast

Pathology

Donald W. Kufe

Oncogenic Signaling by DF3/MUC1 in Human Breast Cancer

Breast

Junjie Chen

Analysis of BRCA1 function in DNA Repair

Breast

Ritu Aneja

Evaluation of centrosome amplification as a risk-predictor for breast cancer aggr

Breast

Tim Greten

Analysis of Cancer-Related Immune Suppressor Mechanisms in Mice

Breast

Powel Brown

ALTERNATIVE DOSING OF EXEMESTANE IN POSTMENOPAUSAL WOMEN WITH STAGE 0-II ER-POSITIVE BREAST CANCER: A RANDOMIZED PRESURGICAL TRIAL

Breast